• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LMNX

LMNX

Daily Target 2X Long LMND ETF

NASDAQFinancial ServicesAsset Management - LeveragedUS

Company Profile

IPO Date

2025-10-16

Sector

Financial Services

Industry

Asset Management - Leveraged

Exchange

NASDAQ

Country

US

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

35.1%

Avg Negative

8.5%

Avg Neutral

56.5%

News Feed

DiaSorin: Surfing The COVID-19 Wave, Culminating In A $1.8 Billion Acquisition Of Luminex

Seeking Alpha·5/6/2021·↑ positive

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Luminex Corp. - LMNX

PRNewsWire·4/16/2021·↓ negative

LUMINEX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Luminex Corporation - LMNX

Business Wire·4/14/2021·↓ negative

Strength Seen in Luminex (LMNX): Can Its 12.4% Jump Turn into More Strength?

Zacks Investment Research·4/13/2021·↑ positive

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Luminex Corporation

PRNewsWire·4/12/2021·↓ negative

SHAREHOLDER ALERT: WeissLaw LLP Investigates Luminex Corporation

PRNewsWire·4/12/2021·↓ negative

Shareholder Alert: Ademi LLP investigates whether Luminex Corporation has obtained a Fair Price in its transaction with DiaSorin

PRNewsWire·4/12/2021·↓ negative

LMNX Stock: Over 9% Increase Pre-Market Explanation

Pulse2·4/12/2021·↑ positive

DiaSorin to acquire U.S.-based Luminex for around $1.8 billion

Market Watch·4/12/2021·↑ positive

Luminex (LMNX) Files EUA Application for New Respiratory Assay

Zacks Investment Research·3/15/2021·↑ positive